Delivery Order SPE2DB22D1202-SPE2DB25FVCB2

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Orencia ClickJect 125 mg/mL pharmaceutical products to the Defense Logistics Agency (DLA). The $12,022.54 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of December 18, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is for the delivery of Orencia Clickject 125 mg/ml pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $16,325.52. This is a delivery order contract with a firm-fixed price pricing type, with a period of performance ending on February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award is for the delivery of Orencia Clickject 125 mg/ml pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $16,724.11, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of January 19, 2024, and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $3,640.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Orencia Clickject 125 mg/ml, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,663.84, is for the delivery of Orencia Clickject 125 mg/ml medication. It is a firm fixed-price delivery order with an ultimate completion date of October 31, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor and holds an...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Orencia Clickject 125 mg/ml medication. The contract, valued at $42,402.29, was awarded by the Defense Logistics Agency (DLA) and has a completion date of June 21, 2024. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Orencia Clickject 125 mg/ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $27,136.20 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,640.93 delivery order contract is for the supply of Orencia Clickject 125 mg/ml, a pharmaceutical product, with a period of performance through April 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of Orencia ClickJect 125 mg/ml, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA for a comprehensive range of medical products and supplies. This specific delivery order, valued at $26,210.62, was awarded on a full and open competition...
This federal contract award is for the delivery of ORENCIA CLICKJECT 125 MG/MLML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $3,331.92, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is July 10, 2024. The contract does not...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVCB2
    Delivery Order

This federal contract award is for the delivery of Orencia Clickject 125 mg/ml to the Defense Logistics Agency (DLA), a defense agency. The $3,594.04 firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 12, 2025 with a completion date of June 13, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs.

Generated 9/11/25, 11:02 AM